Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C
by on Monday, April 16th, 2012 | No Comments
Condition: Advanced Gastrointestinal Malignancies
Intervention: Drug: MLN0264
Sponsor: Millennium Pharmaceuticals, Inc.
Not yet recruiting – verified April 2012
Continued here: Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C
